Zevra Therapeutics, Inc.
USD14.43
+0.42 (+2.97%)
CEO
Neil F. McFarlane
IPO Date
2015-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.09
Prev. Close
$14.01
Day Low
$13.98
Day High
$14.44
52W Low
$7.16
52W High
$14.44
Market Cap
$0.85B
Volume
0.42M
| -3.7 |
| 31 Dec 2023 | FY | 89.3% | -167.7% | -74.4% | -26.7% | 0.71 | 1.18 | -5.0 |
| 31 Dec 2022 | FY | 97.8% | -263.5% | -35.6% | -23.2% | 0.25 | 7.72 | -5.9 |
| 31 Dec 2021 | FY | 92.8% | -29.9% | -6.7% | -6.4% | 0.01 | 27.20 | -30.3 |
| 31 Dec 2020 | FY | 90.2% | -96.0% | 19.2% | -113.8% | -1.06 | 1.11 | -3.5 |
| 31 Dec 2019 | FY | 77.1% | -191.0% | 32.9% | -233.4% | -1.07 | 1.28 | -0.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 84.8% | -211.1% | -1.23 | 1.98 | -0.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 75.4% | -82.7% | -1.63 | 3.99 | -1.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 88.3% | -19.5% | -4.92 | 11.19 | -2.6 |
| 10.2 |
| 30 Sept 2025 | Q3 | 94.0% | -2.1% | -0.4% | -0.2% | 0.47 | 8.62 | -244.5 |
| 30 Jun 2025 | Q2 | 52.2% | 288.7% | 63.7% | 29.2% | 0.53 | 7.85 | 1.6 |
| 31 Mar 2025 | Q1 | 93.4% | -15.2% | -7.6% | -1.8% | 1.51 | 3.02 | -32.7 |
| 31 Dec 2024 | Q4 | 88.7% | -296.8% | -90.1% | -20.1% | 1.52 | 2.53 | -3.1 |
| 30 Sept 2024 | Q3 | 37.7% | -899.2% | -47.6% | -17.3% | 0.86 | 2.88 | -2.5 |
| 30 Jun 2024 | Q2 | 19.7% | -447.9% | -61.3% | -13.8% | 1.83 | 2.00 | -2.4 |
| 31 Mar 2024 | Q1 | 4.7% | -485.3% | -34.0% | -11.0% | 0.91 | 2.10 | -3.2 |
| 31 Dec 2023 | Q4 | 78.9% | -114.6% | -24.5% | -8.8% | 0.71 | 1.18 | -4.1 |